Par Pharma Forecasts Robust Growth
Par Pharmaceuticals Inc. (NYSE:PRX) held its analyst day recently, where it highlighted its performance in 2011 and also provided a peek into expectations for 2012 and beyond. 2011: The Year That Was… Par Pharma develops, manufactures, and markets generic drugs and innovative branded pharmaceuticals for specialty market, through its two division – Strativa Pharmaceuticals (branded [...]
Par Pharmaceuticals Inc. (NYSE:PRX) held its analyst day recently, where it highlighted its performance in 2011 and also provided a peek into expectations for 2012 and beyond.
2011: The Year That Was…
Par Pharma develops, manufactures, and markets generic drugs and innovative branded pharmaceuticals for specialty market, through its two division – Strativa Pharmaceuticals (branded segment) and Par Pharmaceuticals (generic segment).
Strativa currently markets Megace ES (anorexia, cachexia, or … [visit site to read more] or compare Credit Card Rewards and Best Credit Cards